Surgical issues surrounding use of aromatase inhibitors
- 31 May 2005
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 95 (1-5) , 97-103
- https://doi.org/10.1016/j.jsbmb.2005.04.024
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Efficacy of pre-operative Arimidex (anastrozole) compared with tamoxifen (PROACT) as neoadjuvant therapy in postmenopausal women with hormone receptor-positive breast cancerEuropean Journal of Cancer Supplements, 2004
- A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast CancerNew England Journal of Medicine, 2003
- Neoadjuvant endocrine therapy of breast cancer: a surgical perspectiveEuropean Journal Of Cancer, 2002
- Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trialThe Lancet, 2002
- Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter studyAnnals of Oncology, 2001
- Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized TrialJournal of Clinical Oncology, 2001
- Letrozole as Primary Medical Therapy for Locally Advanced and Large Operable Breast CancerBreast Cancer Research and Treatment, 2001
- Long-term follow-up of elderly patients with locoregional breast cancer treated with tamoxifen onlyBritish Journal of Surgery, 1991
- Preoperative chemotherapy followed by mastectomy for locally advanced breast cancerJournal of Surgical Oncology, 1983
- Chemotherapy Before and After Mastectomy in Stage III Breast CancerArchives of Surgery, 1982